YJ. Biotechnology Co.,Ltd.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
One-stop service for the design, construction, operation, and maintenance of micro-intelligent cell preparation facilities. YJ. Biotechnology Co.,Ltd. provides comprehensive solutions ranging from design planning, construction, and operation and maintenance to cell manufacturing technical services, meeting the clinical and commercial demands for immune cells, stem cells, exosomes, and more in a one-stop manner.
Our modular design is highly integrated with our proprietary, high-efficiency manufacturing processes. Even within standard hospital buildings, it enables cost-effective, large-scale cell production in a compact footprint, effectively reducing capital investment and project timelines.
YJ. Biotechnology Co.,Ltd. actively collaborates with domestic and international medical institutions to establish a decentralized, point-of-care cell manufacturing model. This addresses the end-to-end logistical challenges of cell products, helping healthcare institutions enhance the accessibility of cell therapies and improve the overall patient experience.
(The content above was translated by AI.)
Our modular design is highly integrated with our proprietary, high-efficiency manufacturing processes. Even within standard hospital buildings, it enables cost-effective, large-scale cell production in a compact footprint, effectively reducing capital investment and project timelines.
YJ. Biotechnology Co.,Ltd. actively collaborates with domestic and international medical institutions to establish a decentralized, point-of-care cell manufacturing model. This addresses the end-to-end logistical challenges of cell products, helping healthcare institutions enhance the accessibility of cell therapies and improve the overall patient experience.
(The content above was translated by AI.)
Founded Year
2020
Unified Business No.
83482329
Status
Active
Number of Employees
0
Total Paid-in
Capital
201,431,340 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
YJ. Biotechnology Co.,Ltd. was established in March 2020, with its headquarters and R&D center located in Linkou District, New Taipei City, Taiwan. With "pragmatism, professionalism, and innovative excellence" as our core corporate values, we combine Taiwan's top medical and technological strengths to lead the development of advanced cell manufacturing technologies. YJ. Biotechnology Co.,Ltd. possesses 3 key technologies and more than 12 exclusive patents. It is the first enterprise in Taiwan to independently develop a "cell pharmaceutical-grade aseptic isolator" and has become the first cell preparation unit (CPU) to obtain GTP approval from the Ministry of Health and Welfare under the Special Regulations using an aseptic isolator cell manufacturing process. Based on the PIC/S GMP-in-Design YJ intelligent cell manufacturing platform, we continue to break through the boundaries of cell manufacturing technology, providing one-stop services to meet the needs of various cells and their derivatives for treating a wide range of diseases and cancers. YJ. Biotechnology Co.,Ltd. is committed to expanding into overseas markets. Adopting a dual-engine development strategy, we actively cooperate with domestic and foreign medical institutions, academic and research institutions, and industry supply chains to promote the clinical-side decentralized cell manufacturing model, accelerate clinical trials of new drug formulations, and lead Taiwan's cell manufacturing industry to align with international standards.
(The content above was translated by AI.)
(The content above was translated by AI.)
